Managed Account Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$340K Buy
5,834
+1,818
+45% +$98K ﹤0.01% 2383
2015
Q1
$203K Buy
4,016
+2,224
+124% +$109K ﹤0.01% 2434
2014
Q4
$81K Buy
1,792
+736
+70% +$30.8K ﹤0.01% 2414
2014
Q3
$39K Buy
1,056
+568
+116% +$22.5K ﹤0.01% 2445
2014
Q2
$22K Sell
488
-816
-63% -$37K ﹤0.01% 2492
2014
Q1
$56K Buy
1,304
+328
+34% +$14.6K ﹤0.01% 2361
2013
Q4
$41K Sell
976
-89
-8% -$3.38K ﹤0.01% 2379
2013
Q3
$36K Buy
1,065
+23
+2% +$751 ﹤0.01% 2325
2013
Q2
$33K Buy
+1,042
New +$33.8K ﹤0.01% 2322

Other funds holding CNMD

Managed Account Advisors's CNMD Position: Q2 2015 in Review

Managed Account Advisors increased its CONMED (CNMD) stake by 45% in Q2 2015, buying an estimated $98K and bringing the position to 5,834 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Managed Account Advisors first reported a position in CNMD in Q2 2013 and has held it in 9 quarters since. 156 funds tracked by Wall St. Rank hold CNMD as of Q2 2015.

  • Managed Account Advisors held 5,834 shares of CONMED worth $340K as of Q2 2015.
  • Managed Account Advisors bought 1,818 CONMED shares in Q2 2015, an estimated $98K.
  • CONMED made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2383 holding.
  • Managed Account Advisors first reported a position in CONMED in Q2 2013 and has held it in 9 quarters since.
  • 156 funds tracked by Wall St. Rank held CONMED as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.